What Should I Do to Prepare for My First Lu-177 DOTATATE Infusion If My Neuroendocrine Tumor Has Metastasized?

Getting your first Lu-177 DOTATATE infusion can feel hopeful and a bit overwhelming. You may have spent months getting scans, blood tests, and specialist opinions. Now the date is set. Knowing what to expect—and what to do before you arrive—makes a real difference in how the day goes.

This article walks you through the preparation process in plain language. It covers what to do in the weeks before your infusion, what happens on treatment day, and what to expect when you go home. Nothing here replaces the specific guidance your care team will give you, but having a clear picture ahead of time helps.

What Is Lu-177 DOTATATE and Why Does Preparation Matter?

Lu-177 DOTATATE—sometimes called Lutathera—is a type of targeted radiation therapy for neuroendocrine tumors (NETs). It works by attaching a radioactive atom to a molecule that seeks out somatostatin receptors, which are proteins found on many NET cells. The treatment is given as an IV infusion directly into a vein.

Preparation matters for two key reasons. First, the treatment places strain on your kidneys. A special IV fluid called an amino acid solution is given alongside the DOTATATE to help protect them. Second, because Lu-177 DOTATATE is radioactive, there are specific safety steps you must follow after you go home. Understanding these steps ahead of time reduces stress on the day itself.

According to a clinical guide to PRRT with 177Lu-DOTATATE published in the journal Cancers, delivering this therapy safely involves close coordination between nuclear medicine physicians, pharmacists, nursing staff, and the patient—which is why your care team will be in contact with you well before your first cycle begins.

Weeks Before Your First Infusion: What to Organize

Make Sure Your Scans and Labs Are Current

Before receiving Lu-177 DOTATATE, your care team needs to confirm that your tumor expresses somatostatin receptors. This is usually done with a Ga-68 DOTATATE PET/CT scan. If your most recent scan is more than a few months old, your team may want an updated one before treatment begins.

Blood tests are required before each cycle. These typically include kidney function markers, a complete blood count (CBC), and liver enzymes. If any of these fall outside acceptable ranges, your team may need to delay or adjust treatment. If you have kidney disease, diabetes, or another condition that could affect your eligibility, discuss it openly with your team. Our article on what kidney disease and diabetes mean for Lu-177 DOTATATE eligibility explains how comorbidities are reviewed before a patient is approved for PRRT.

Talk to Your Team About Your Current Medications

If you are already taking a long-acting somatostatin analog—such as octreotide LAR or lanreotide—you will likely need to pause it before your infusion. These medications bind to the same somatostatin receptors that the DOTATATE targets. If the analog is still active in your system on treatment day, it may reduce how effectively the therapy reaches your tumor cells.

A best practices paper for PRRT care coordination published in Frontiers in Oncology notes that most centers ask patients to hold long-acting somatostatin analogs for at least four to six weeks before each PRRT cycle. Short-acting formulations are typically held for a shorter period—often 24 hours or less. Your team will give you the exact timing for your specific medication and situation.

Tell your entire care team about every medication you take—including vitamins, herbal products, and over-the-counter medicines. Some may need to be paused or reviewed. Do not stop any medication on your own without checking with your doctor first.

Plan the Practical Logistics Early

Treatment day is a long day. You will likely spend four to six hours or more at the treatment center. Planning ahead reduces last-minute stress:

• Arrange for someone to drive you home. You may feel tired after the infusion and should not drive yourself.
• If you are traveling from another city or country, book accommodation close to the treatment center for at least the night before and night of treatment.
• Bring photo ID, your insurance card, and any paperwork your care team has asked you to complete in advance.
• If you have young children, infants, or a pregnant person at home, arrange for extra help during the first few days after treatment—radiation safety precautions may limit close physical contact.

If you plan to travel between your treatment cycles, our article on traveling between Lu-177 DOTATATE infusions covers what patients need to know about radiation safety and logistics on the road.

The Week Before Your Infusion

Stay Well Hydrated

Good hydration in the days leading up to your infusion supports your kidney function. Ask your care team whether they have a specific fluid intake target for you in the days before treatment. Staying well hydrated on the day itself is especially important. You will be encouraged to drink water regularly throughout the day and to urinate frequently. This helps clear the radioactive compound from your body more quickly.

What to Eat Before Your Infusion

Most treatment centers do not require fasting before Lu-177 DOTATATE. Eating a light, bland meal before you arrive is generally fine. Avoid a very large or heavy meal right before treatment, because the amino acid solution given during the infusion can cause nausea in some patients. Your specific center may have its own dietary guidance, so ask your nurse or treatment coordinator in advance rather than assuming.

Pack for a Long Day

You will be at the treatment center for several hours. Consider bringing:

• Comfortable, loose-fitting clothes—the IV lines go into your arms, so avoid tight or restrictive sleeves
• A book, tablet, or headphones to pass the time during the infusion
• Light snacks and a water bottle (confirm this is allowed at your center)
• A written list of all your current medications and any known allergies
• A phone charger
• Any comfort items that help you feel calm and at ease

What Happens on Treatment Day

Arrival and Initial Assessment

When you arrive, nursing staff will check your vital signs—temperature, pulse, and blood pressure. They will review your most recent lab results to confirm you are cleared for treatment that day. Two IV lines are typically placed, often one in each arm. This setup allows the amino acid solution and the DOTATATE to be infused at the same time through separate IV channels.

The Amino Acid Infusion: Protecting Your Kidneys

The amino acid solution (AAS) is one of the most important parts of each PRRT treatment. Its purpose is to reduce the amount of radiation your kidneys absorb during the infusion. According to the clinical guide to 177Lu-DOTATATE referenced above, the AAS is started about 30 minutes before the DOTATATE infusion and continues for four to six hours total—well after the DOTATATE itself has finished.

Because the amino acid solution can cause nausea, your care team will give you an anti-nausea medication through the IV before the infusions begin. This is standard practice at PRRT centers worldwide. If you have had severe nausea with past treatments or with the amino acid solution in particular, tell your nurse—additional anti-nausea support may be available to you.

The Lu-177 DOTATATE Infusion

The Lu-177 DOTATATE infusion typically takes about 20 to 30 minutes. Your care team gives it slowly at first, so they can watch for any reaction and make sure you're comfortable. You won't feel the radiation, and the infusion isn't painful. After it finishes, you'll keep receiving IV fluids and the amino acid solution while staff monitors your vital signs.

Most patients receive four treatment cycles, spaced approximately eight weeks apart. The plan for your situation may differ. Your oncologist and nuclear medicine physician will walk you through the full schedule before you begin.

Post-Infusion Imaging Scan

Several hours after the infusion—usually around three to four hours—your team will take a whole-body imaging scan. This post-therapy scan shows whether the DOTATATE has reached your tumor and how it is distributed throughout your body. It's a routine and important part of each PRRT cycle. The scan is painless. You just lie still on an imaging table while the camera moves around you.

Going Home

In the United States, most patients receive PRRT as outpatients and go home the same day. In some countries—including parts of Europe and some centers in India—you may need to stay overnight or for a few days due to local radiation safety rules. Your care team will tell you exactly what to expect at your center.

Before you leave, a nurse or radiation safety officer will review your at-home precautions in detail. Make sure you understand every instruction before you walk out the door. Ask for a written copy of your safety instructions, and make sure you have an after-hours phone number to call if any problems come up.

Radiation Safety at Home After Your First Infusion

After treatment, some radioactivity stays in your body and gradually decreases as the Lu-177 decays. Most of it leaves your body through urine within 24 to 48 hours. The following precautions are based on published radiation safety guidance for PRRT patients.

A paper on radiation precautions for outpatient and inpatient 177Lu-DOTATATE PRRT, published in the European Journal of Nuclear Medicine and Molecular Imaging, describes these core home safety steps:

Distance and Contact

• Keep at least one metre (about three feet) from other people in your household for the first two to three days after treatment.
• Avoid prolonged close contact with pregnant women, infants, and young children. Your team will specify the exact timeframe, which may be longer than the general household precaution.
• Sleep in a separate bed from your partner for the first seven days after each infusion.

Toilet and Hygiene Precautions

• Sit down when using the toilet. This reduces splashing of radioactive urine. Flush twice after each use and wash your hands thoroughly.
• Drink plenty of fluids on treatment day and the following day. Aim to urinate at least once per hour throughout the treatment day.
• Shower daily for the first seven days after each infusion.

Handling Body Fluids and Laundry

• Wear disposable gloves if you handle blood, urine, stool, or vomit in the first few days after treatment.
• Wash any clothing or bedding soiled with bodily fluids promptly and separately from other laundry.

These precautions don't last forever. By about two weeks after treatment, most of the radioactivity has cleared from your body. Your team will give you specific clearance timelines based on your kidney function and other factors.

Side Effects to Watch for After the First Cycle

The most common side effects in the days following a Lu-177 DOTATATE infusion include fatigue, mild nausea, and temporary changes in blood counts. These are usually manageable and tend to improve between cycles. Your care team will schedule blood tests regularly between infusions to monitor your bone marrow and kidney function over time.

Rare but more serious side effects—including larger drops in blood cell counts or changes in kidney function—need careful monitoring throughout your treatment. This is one reason why lab checks between cycles are just as important as your treatment day. Do not skip scheduled blood draws, even if you are feeling well.

For a full overview of what to watch for and how your team will manage side effects at each stage, see our article on Lu-177 DOTATATE side effects and how they are managed for gastroenteropancreatic neuroendocrine tumors.

Questions to Ask Your Care Team Before Your First Infusion

Going into your first treatment with a prepared list of questions helps you feel more in control. Consider asking:

• When exactly do I need to stop my somatostatin analog, and when can I restart it after the infusion?
• Are there any other medications or supplements I should pause before treatment?
• What should I eat and drink the day before and the morning of the infusion?
• How long will I be at the center, and will I need to stay overnight?
• What written radiation safety instructions will I take home?
• Who do I call if I feel unwell after going home, especially outside of regular clinic hours?
• What blood tests or scans will I need between this cycle and the next one?
• Can my caregiver or family member stay with me during part of the infusion day?

When to Talk to Your Doctor

Speak with your oncologist or nuclear medicine physician before your first infusion if you have kidney disease, are currently taking a somatostatin analog, have recently completed another form of radiation treatment, or have questions about any of your current medications. After your infusion, contact your care team right away if you develop a fever, severe nausea or vomiting, persistent or new pain, difficulty breathing, or any other symptom that concerns you. Do not wait for your next scheduled appointment.

This article is for general information and is not a substitute for medical advice. Always consult your oncologist or care team about your specific situation.